Sanofi extends $180M to California T cell engager startup Kalinews2026-03-23T11:00:42+00:00March 23rd, 2026|Endpoints News|
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovationnews2026-03-20T11:40:21+00:00March 20th, 2026|Endpoints News|
Collegium is acquiring Corium’s approved ADHD drug for $650Mnews2026-03-19T14:55:37+00:00March 19th, 2026|Endpoints News|
Drugmakers consider licensing deal tweaks to soften MFN impactnews2026-03-17T16:47:55+00:00March 17th, 2026|Endpoints News|
Roivant CEO, bullish on internal growth, dodges M&A chatternews2026-03-13T19:12:27+00:00March 13th, 2026|Endpoints News|
Breakout Ventures closes $114M fund, plans 20 investmentsnews2026-03-10T11:00:55+00:00March 10th, 2026|Endpoints News|
Universal Health Services buys Talkspace for $835Mnews2026-03-09T15:37:23+00:00March 9th, 2026|Endpoints News|
GSK licenses linerixibat for liver disease itch to Alfasigma for $300M upfrontnews2026-03-09T10:29:43+00:00March 9th, 2026|Endpoints News|
Servier to buy Day One for $2.5B, gaining rare oncology medicinesnews2026-03-06T15:54:59+00:00March 6th, 2026|Endpoints News|
Tenaya wins support from Alnylam in cardio disease pactnews2026-03-05T16:06:00+00:00March 5th, 2026|Endpoints News|
